The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: invega sustenna     Quarter: 2016Q3

Total Records: 380     Number of Pages: 19

DRUGNAME PT EventCount
INVEGA SUSTENNA Language disorder 6
INVEGA SUSTENNA Medication residue present 6
INVEGA SUSTENNA Memory impairment 6
INVEGA SUSTENNA Needle issue 6
INVEGA SUSTENNA Rhabdomyolysis 6
INVEGA SUSTENNA Sexual dysfunction 6
INVEGA SUSTENNA Therapeutic response unexpected 6
INVEGA SUSTENNA Accidental exposure to product 5
INVEGA SUSTENNA Activities of daily living impaired 5
INVEGA SUSTENNA Blood creatine phosphokinase increased 5
INVEGA SUSTENNA Cognitive disorder 5
INVEGA SUSTENNA Confusional state 5
INVEGA SUSTENNA Dehydration 5
INVEGA SUSTENNA Haematochezia 5
INVEGA SUSTENNA Impaired work ability 5
INVEGA SUSTENNA Judgement impaired 5
INVEGA SUSTENNA Libido decreased 5
INVEGA SUSTENNA Mobility decreased 5
INVEGA SUSTENNA Muscle spasms 5
INVEGA SUSTENNA Obesity 5

Total Records: 380     Number of Pages: 19